Cargando…
Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer
PURPOSE: To evaluate treatment outcomes and prognostic factors in non-small cell lung cancer (NSCLC) patients treated with concurrent chemoradiation. MATERIALS AND METHODS: From January 2005 to June 2009, 51 patients were treated with concurrent chemoradiation for 3 different aims: locally advanced...
Autores principales: | Lee, Dong-Soo, Kim, Yeon-Sil, Kang, Jin-Hyoung, Lee, Sang-Nam, Kim, Young-Kyoun, Ahn, Myung-Im, Han, Dae-Hee, Yoo, Ie-Ryung, Wang, Young-Pil, Park, Jae-Gil, Yoon, Sei-Chul, Jang, Hong-Seok, Choi, Byung-Oak |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072533/ https://www.ncbi.nlm.nih.gov/pubmed/21509161 http://dx.doi.org/10.4143/crt.2011.43.1.32 |
Ejemplares similares
-
FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer
por: Kim, Giwon, et al.
Publicado: (2011) -
Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma
por: Ha, Hyerim, et al.
Publicado: (2021) -
Radiation nephritis: (99m)Tc hydroxydiphosphonate bone scan, (99m)Tc dimercaptosuccinic acid renal scan, and (18)F-FDG PET/CT findings
por: Park, Hye Lim, et al.
Publicado: (2018) -
Achalasia Combined with Esophageal Cancer Treated by Concurrent Chemoradiation Therapy
por: Park, Jun Chul, et al.
Publicado: (2009) -
Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients
por: Ko, Yoon Ho, et al.
Publicado: (2007)